Article
[P53 genes and malignant hematologic diseases].
Bulletin du cancer - 1 Aug 1993
Jonveaux P
Abstract excerpt
Mutations of the P53 tumor suppressor gene represent the most common genetic lesion in human solid tumors. In hematological malignancies, P53 alterations are detected in the evolution of the chronic myelogenous leukemia to myeloid blast crisis. P53 mutations were also found to be associated with Burkitt's lymphoma and HTLV-1 related adult T-cell leukemia. These results support the notion that alterations of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
